Catalyst Funds Management Pty Ltd
Position in SENS — Senseonics Holdings, Inc.
CIK 1896150
SYDNEY NSW, C3
Position in SENS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$101,898
+$91,796 QoQ
Shares Held
15,300
+1887.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SENS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Catalyst Funds Management Pty Ltd holds $6,305,652 across 14 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
32,301 | $2,930,992 | |
| 2 | SYK |
Stryker Corp
|
2,680 | $843,771 | |
| 3 | BSX |
Boston Scientific Corp
|
8,500 | $362,780 | |
| 4 | EW |
Edwards Lifesciences Corp
|
3,900 | $352,794 | |
| 5 | PEN |
Penumbra Inc
|
1,101 | $347,640 | |
| 6 | PODD |
Insulet Corp
|
2,101 | $319,877 | |
| 7 | CTKB |
Cytek Biosciences, Inc.
|
62,500 | $276,875 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
3,000 | $258,270 |
All Filings in SENS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $101,898 | 15,300 | Shares | Sole | 2026-05-11 | |
| 2025-03-31 | $10,102 | 15,400 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $10,356 | 29,590 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,806 | 29,590 | Shares | Sole | 2024-12-18 | |
| 2024-03-31 | $31,323 | 58,990 | Shares | Sole | 2024-12-05 | |
| No filing history on record for this holder in this stock. | ||||||